Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03576716 · ClinicalTrials.gov registry record · Phase 1
Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT03576716 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 19 participants.
The verdict
NCT03576716, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
The goal of this study is to determine how 25(OH)D3 clearance is affected by vitamin D3 supplementation using a gold standard pharmacokinetic approach.
Interventions
- DRUG D6-25-hydroxyvitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2021-01-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03576716
The ClinicalTrials.gov registry entry for NCT03576716 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which D6-25-hydroxyvitamin D3 is the first listed.
NCT03576716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03576716 about?
NCT03576716 is a clinical study titled "Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation". The goal of this study is to determine how 25(OH)D3 clearance is affected by vitamin D3 supplementation using a gold standard pharmacokinetic approach.
What is the current status of trial NCT03576716?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2018-06-01. Estimated completion is 2021-01-01.
What interventions are being tested in trial NCT03576716?
The interventions under investigation include: D6-25-hydroxyvitamin D3 (DRUG).
Who is sponsoring clinical trial NCT03576716?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.